Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
01 2019
Historique:
received: 28 05 2018
revised: 28 09 2018
accepted: 09 11 2018
pubmed: 16 11 2018
medline: 29 5 2019
entrez: 16 11 2018
Statut: ppublish

Résumé

Whether human IL-10-producing regulatory T cells ("Tr1") represent a distinct differentiation lineage or an unstable activation stage remains a key unsolved issue. Here, we report that Eomesodermin (Eomes) acted as a lineage-defining transcription factor in human IFN-γ/IL-10 coproducing Tr1-like cells. In vivo occurring Tr1-like cells expressed Eomes, and were clearly distinct from all other CD4

Identifiants

pubmed: 30431161
doi: 10.1002/eji.201847722
doi:

Substances chimiques

EOMES protein, human 0
T-Box Domain Proteins 0
Interleukin-10 130068-27-8
Interferon-gamma 82115-62-6
Granzymes EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

96-111

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Paola Gruarin (P)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Stefano Maglie (S)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Marco De Simone (M)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Barbara Häringer (B)

German Rheumatology Research Center DRFZ, Berlin, Germany.
Charitè Research Center for Immunosciences RCIS, Berlin, Germany.

Chiara Vasco (C)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Valeria Ranzani (V)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Roberto Bosotti (R)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Johanna S Noddings (JS)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Paola Larghi (P)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Federica Facciotti (F)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Maria L Sarnicola (ML)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Martina Martinovic (M)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Mariacristina Crosti (M)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Monica Moro (M)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Riccardo L Rossi (RL)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Maria E Bernardo (ME)

Ospedale Pediatrico Bambino Gesù, Dipartimento Onco-Ematologia e Medicina Trasfusionale, Rome, Italy.

Flavio Caprioli (F)

Unità Operativa di Gastroenterologia ed Endoscopia, Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Franco Locatelli (F)

Ospedale Pediatrico Bambino Gesù, Dipartimento Onco-Ematologia e Medicina Trasfusionale, Rome, Italy.

Grazisa Rossetti (G)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Sergio Abrignani (S)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.
Department of Clinical Science and Community Health (DISCCO), University of Milan, Milan, Italy.

Massimiliano Pagani (M)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

Jens Geginat (J)

INGM-National Institute of Molecular Genetics "Romeo ed Enrica Invernizzi", Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH